Antisense mapping of opioid receptor clones: Effects upon 2-deoxy-D- glucose-induced hyperphagia Academic Article uri icon


MeSH Major

  • Biomarkers, Tumor
  • CA-125 Antigen
  • Indicators and Reagents
  • Product Recalls and Withdrawals


  • Antisense oligodeoxynucleotides (AS ODNs) directed against exons 1 and 2 of the MOR-1 clone significantly and markedly reduced (81-93%) hyperphagia induced by the anti-metabolic glucose analogue, 2-deoxy-d-glucose (2DG) across a 4 h time course. AS ODNs directed against exons 3 or 4 of the MOR-1 clone had a more limited (1-2 h) duration of action upon 2DG-induced hyperphagia. 2DG-induced hyperphagia was significantly reduced by AS ODNs directed against exon 2 (44-51%), but not exons 1 or 3 of the KOR-1 clone across a 4 h time course. Whereas an AS ODN probe directed against the KOR3/ORL-1 clone produced small (36%), but significant reductions in 2DG-induced hyperphagia, an AS ODN probe directed against the DOR-1 clone was ineffective. These data provide further converging evidence for the roles of primarily mu, but also kappa1 and kappa3 opioid receptors in mediating the hyperphagic effects of glucoprivation.

publication date

  • June 1998



  • Academic Article


Digital Object Identifier (DOI)

  • 10.1016/S0006-8993(98)00331-X

Additional Document Info

start page

  • 359

end page

  • 63


  • 794


  • 2